WALTHAM, Mass., March 22, 2018 /PRNewswire/ -- Respiratory Motion, Inc. reported today that FDA clearance was received for the newest version of its ExSpiron Minute Ventilation (MV) monitoring system ...
OBJECTIVE: We performed a prospective, randomized clinical trial to compare the usefulness of the minute ventilation test (MVT) with clinical judgement in predicting readiness for extubation in ...
Waltham, MA (February 22, 2016) Respiratory Motion, Inc. developer of ExSpiron, the ONLY patient monitor measuring non-invasive Minute Ventilation, critical for early identification of potentially ...
Respiratory Motion, Inc. Receives 510(k) Clearance for ExSpiron™ Monitor, the First Monitor to Provide Continuous Minute Ventilation Data in Non-Ventilated Patients Respiratory Motion, Inc. today ...
Background The increasing number of patients treated by long-term non-invasive ventilation (NIV) challenges the capacity of ...
“We have never before been able to quantify the influence of pain agents on the respiratory system with such fidelity,” reported Gary Mullen, M.D., a practicing anesthesiologist at Vidant Medical ...